Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.57 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | GRN | P28799 | 1/20 | 0.49 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.49 |
| ▸ | MME | P08473 | 1/20 | 0.49 |
| ▸ | LAP3 | P28838 | 3/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.47 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6256944 | 1.00 | ALDH1A1 (0.60) | ALDH1A1PLA2G2APLA2G5MEN1LMNA | |
| Benzene SCHEMBL27688929 | 0.96 | ALDH1A1 (0.56) | ALDH1A1PLA2G2APLA2G5MEN1LMNA | |
| SCHEMBL15692314 | 0.93 | ALDH1A1 (0.53) | ALDH1A1PLA2G2APLA2G5MEN1LMNA | |
| SCHEMBL15649008 | 0.93 | ALDH1A1 (0.53) | ALDH1A1PLA2G2APLA2G5MEN1LMNA | |
| Leucine SCHEMBL15648550 | 0.90 | SLC7A5 (0.56) | ALDH1A1PLA2G2APLA2G5MEN1LMNA | |
| SCHEMBL14637109 | 0.89 | PLA2G2A (0.62) | ALDH1A1PLA2G2APLA2G5MEN1LMNA | |
| SCHEMBL9073825 | 0.88 | ALDH1A1 (0.51) | ALDH1A1PLA2G2APLA2G5MEN1LMNA | |
| SCHEMBL12228501 | 0.87 | ALDH1A1 (0.47) | ALDH1A1PLA2G2APLA2G5MEN1LMNA | |
| SCHEMBL7333737 | 0.87 | PLA2G2A (0.69) | ALDH1A1PLA2G2APLA2G5MEN1LMNA | |
| SCHEMBL9664224 | 0.87 | PLA2G2A (0.69) | ALDH1A1PLA2G2APLA2G5MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230368914-A1 | SYSTEMS AND METHODS FOR COMPUTER-IMPLEMENTED METABOLITE ANALYSIS AND PREDICTION FOR ANIMAL SUBJECTS | DSM IP ASSETS B.V. (NL) | 2023-11-16 | — | — | US | claimed |
| US-20220221433-A1 | MASS SPECTROMETRY ASSAY METHODS FOR DETECTION OF METABOLITES | METABOLON, INC. | 2022-07-14 | — | — | US | claimed |
| EP-3977112-A1 | MASS SPECTROMETRY ASSAY METHODS FOR DETECTION OF METABOLITES | Metabolon Inc. (US) | 2022-04-06 | — | — | EP | claimed |
| CN-113892029-A | Mass spectrometry method for detecting metabolites | 梅塔博隆股份有限公司 | 2022-01-04 | — | — | CN | claimed |
| WO-2020242744-A1 | MASS SPECTROMETRY ASSAY METHODS FOR DETECTION OF METABOLITES | METABOLON, INC. (US) | 2020-12-03 | — | — | WO | claimed |
| US-4859653-A | Use of compositions of matter containing N-acylates of alpha aminoacids for the treatment of skin | MORELLE JEAN V (FR) | 1989-08-22 | — | — | US | claimed |
| US-20250000948-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2025-01-02 | — | — | US | disclosed |
| US-20240390433-A1 | GENETICALLY MODIFIED BACILLUS SUBTILIS STRAIN AND USE AS A LIVE DELIVERY AND PRODUCTION SYSTEM | BIOMEDIT, INC. | 2024-11-28 | — | — | US | disclosed |
| EP-4433093-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-09-25 | — | — | EP | disclosed |
| CN-118488855-A | Solid composition comprising peptide or protein and acylated amino acid | 阿道恰公司 | 2024-08-13 | — | — | CN | disclosed |
| EP-4387638-A1 | GENETICALLY MODIFIED BACILLUS SUBTILIS STRAIN AND USE AS A LIVE DELIVERY AND PRODUCTION SYSTEM | BiomEdit, LLC (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-4386090-A1 | METHOD FOR DETERMINING AND IMPROVING THE POTENTIAL EFFICACY OF ANTICANCER TREATMENT | ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (FR) | 2024-06-19 | — | — | EP | disclosed |
| EP-4299057-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-01-03 | — | — | EP | disclosed |
| US-6149924-A | FOR TOPICAL APPLICATION | BIOMED RESEARCH & TECHNOLOGIES, INC. (US) | 2000-11-21 | — | — | US | disclosed |
| WO-2000004870-A2 | COMPOSITION FOR ENHANCING EPIDERMAL LIPID PRODUCTION | BIOMED RESEARCH AND TECHNOLOGIES, INC. (US) | 2000-02-03 | — | — | WO | disclosed |
| EP-0584374-B1 | PEPTIDE WHICH INHIBITS PHOSPHOLIPASE C | KYOWA HAKKO KOGYO KK (JP) | 1997-09-24 | — | — | EP | disclosed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | disclosed |
| US-4859653-A | Use of compositions of matter containing N-acylates of alpha aminoacids for the treatment of skin | MORELLE JEAN V (FR) | 1989-08-22 | — | — | US | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000948-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | NPPA, BCAT1, ANPEP | ALDH1A1 4701/4885PLA2G2A 1852/4885PLA2G5 2191/4885 |
| US-20240390433-A1 | GENETICALLY MODIFIED BACILLUS SUBTILIS STRAIN AND USE AS A LIVE DELIVERY AND PRODUCTION SYSTEM | BLVRB, GLB1, GUSB | ALDH1A1 4757/4885PLA2G2A 155/4885PLA2G5 262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.